Determination of morphological and molecular adaptations in ventral tegmental area dopamine neurons by chronic morphine
慢性吗啡对腹侧被盖区多巴胺神经元形态和分子适应的测定
基本信息
- 批准号:9325248
- 负责人:
- 金额:$ 3.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-04-07 至 2019-04-06
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinity ChromatographyAutopsyAversive StimulusBehaviorBehavioralBioinformaticsBrain regionCandidate Disease GeneCellsChronicCocaineDataDendritic SpinesDetectionDopamineDrug abuseElectrophysiology (science)Enterobacteria phage P1 Cre recombinaseEpidemicExhibitsFunctional disorderFutureGene ExpressionGene Expression ProfileGenesGeneticGenetic TranscriptionGenomic approachGoalsHeroinHeterogeneityHumanImmunohistochemistryInjectableInjection of therapeutic agentKnowledgeLabelLinkMediatingMediator of activation proteinMessenger RNAMicroscopyMolecularMorphineMorphologyMusNeuronsNucleus AccumbensOpiatesPharmaceutical PreparationsPlayPrefrontal CortexPrevalencePropertyProteinsRelapseResearchReverse Transcriptase Polymerase Chain ReactionRewardsRibosomesRodent ModelRoleRunningSamplingSeriesSignal TransductionStructureTechniquesTherapeuticTrainingTranscriptTransgenic MiceTranslatingTyrosine 3-MonooxygenaseVentral Tegmental AreaViralWorkaddictionbehavioral outcomecareercell typecocaine overdosedensitydopaminergic neuronexperimental studyfallsfunctional adaptationgene inductionheroin overdoseimprovedinnovationinsightneuroadaptationneuronal cell bodynovelopioid abuseoptogeneticsoverdose deathprescription opiateresponsereward processingscreeningstemtranscriptometranscriptome sequencingvector
项目摘要
Opiate abuse is an epidemic in the US, where opiates have a high relapse rate, and unintentional overdose
deaths have tripled from 2001 to 2013. Despite the prevalence of opiate abuse, relatively little is known about
the neuroadaptations that occur with chronic use. We previously determined that chronic opiate exposure
induces a unique change in the size of dopamine (DA) neurons in the ventral tegmental area (VTA), a key brain
region in the mesocorticolimbic reward circuit, and decreased VTA DA soma size was also observed in post-
mortem human samples of heroin addicts, suggesting translational relevance. Moreover, we have demonstrated
that changes in soma size are correlated with VTA DA neuronal activity and reward processing in rodent models,
suggesting a functional link. However, further understanding of opiate-induced structural and functional
neuroadaptations of VTA DA neurons has been limited by VTA cellular heterogeneity and techniques to isolate
and examine specific subsets of VTA DA neurons. For example, unbiased genomic approaches necessary to
identify novel molecular mediators have been limited to homogenization of the entire VTA, which includes
multiple neuron types, not just DA cells. Further, it has become increasingly clear through optogenetic studies
that VTA DA neurons themselves are diverse, as subsets of VTA DA neurons are differentially activated by
rewarding or aversive stimuli depending on their projection target, e.g. the nucleus accumbens (NAc) or
prefrontal cortex (PFC). Thus, this proposal seeks to address the limitations stemming from VTA cellular
heterogeneity through the use of cutting-edge viral and molecular techniques, addressing the central hypothesis
that chronic morphine induces structural plasticity in VTA DA neurons in a projection-specific manner and is
mediated by transcriptional changes in VTA DA neurons. Aim 1 will determine whether chronic morphine induces
circuit-specific changes in structural plasticity (soma size and dendritic spine density) through injection of
retrograde adeno-associated vectors that express fluorescent proteins in a Cre-recombinase dependent manner
into the NAc and PFC of tyrosine hydroxylase (TH)-Cre mice. Preliminary data suggest differences in basal and
morphine-induced soma size between NAc- and PFC-projecting VTA DA neurons. Aim 2 will use an innovative
cell type-specific purification technique, Translating Ribosome Affinity Purification (TRAP) to isolate mRNA
specifically from VTA DA neurons and assess gene expression changes in candidate genes, as well as novel
genes via RNA-sequencing, that may mediate morphine-induced structural and functional adaptations. Our
previous RNA-sequencing data have shown that chronic morphine induces a unique gene expression pattern in
the VTA compared to cocaine; these studies will determine whether such changes are driven specifically by VTA
DA neurons. Together, this work is expected to advance the understanding of how chronic opiate exposure alters
the structure and function of VTA DA neurons and to identify novel mechanisms underlying mesocorticolimbic
circuit dysfunction.
阿片类药物滥用在美国是一种流行病,阿片类药物的复发率很高,
从2001年到2013年,死亡人数增加了两倍。尽管阿片类药物滥用普遍存在,但人们对阿片类药物的使用知之甚少。
长期使用会产生的神经适应。我们之前确定长期接触阿片类药物
诱发腹侧被盖区(VTA)多巴胺(DA)神经元大小的独特变化,
在中皮质边缘奖赏回路中,也观察到VTA DA索马体大小减少。
海洛因成瘾者的尸体样本,这表明翻译相关性。此外,我们已经证明,
在啮齿动物模型中,索马大小的变化与腹侧被盖区DA神经元活动和奖赏处理相关,
这表明存在功能性联系然而,进一步了解阿片诱导的结构和功能
腹侧被盖区DA神经元的神经适应受到腹侧被盖区细胞异质性和分离技术的限制,
检查腹侧被盖区DA神经元的特定子集例如,公正的基因组方法,
鉴定新的分子介质仅限于整个VTA的均质化,其包括
多种类型的神经元,而不仅仅是DA细胞此外,通过光遗传学研究,
腹侧被盖区DA神经元本身是多样的,因为腹侧被盖区DA神经元的子集被不同的激活,
奖励或厌恶刺激,取决于它们的投射目标,例如丘脑核(NAc)或
前额叶皮层(PFC)。因此,该提议寻求解决VTA蜂窝网络所产生的限制。
通过使用尖端的病毒和分子技术,解决中心假设
慢性吗啡以投射特异性方式诱导腹侧被盖区DA神经元的结构可塑性,
VTA DA神经元的转录变化介导的。目的1将确定慢性吗啡是否诱导
通过注射,在结构可塑性(索马大小和树突棘密度)的电路特异性变化
以Cre重组酶依赖性方式表达荧光蛋白的逆行腺相关载体
酪氨酸羟化酶(TH)-Cre小鼠的NAc和PFC。初步数据表明,基础和
吗啡诱导的索马体在投射NAc和PFC的VTA DA神经元之间的大小。Aim 2将采用创新的
细胞类型特异性纯化技术,翻译核糖体亲和纯化(TRAP)以分离mRNA
特别是从腹侧被盖区DA神经元,并评估候选基因的基因表达变化,以及新的
基因通过RNA测序,这可能介导吗啡诱导的结构和功能适应。我们
先前的RNA测序数据表明,慢性吗啡诱导了一种独特的基因表达模式,
VTA与可卡因相比;这些研究将确定这种变化是否是由VTA专门驱动的
DA神经元。总之,这项工作有望促进对慢性阿片类药物暴露如何改变
腹侧被盖区DA能神经元结构和功能,并确定新的机制,
电路功能障碍
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sarah Emily Cooper Simmons其他文献
Sarah Emily Cooper Simmons的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10506915 - 财政年份:2021
- 资助金额:
$ 3.97万 - 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
- 批准号:
10325006 - 财政年份:2021
- 资助金额:
$ 3.97万 - 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
- 批准号:
1746198 - 财政年份:2018
- 资助金额:
$ 3.97万 - 项目类别:
Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
- 批准号:
512537-2017 - 财政年份:2017
- 资助金额:
$ 3.97万 - 项目类别:
University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
- 批准号:
1404605 - 财政年份:2014
- 资助金额:
$ 3.97万 - 项目类别:
Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
- 批准号:
1263713 - 财政年份:2013
- 资助金额:
$ 3.97万 - 项目类别:
Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
- 批准号:
425749-2012 - 财政年份:2012
- 资助金额:
$ 3.97万 - 项目类别:
Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
- 批准号:
1159886 - 财政年份:2012
- 资助金额:
$ 3.97万 - 项目类别:
Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
- 批准号:
19560760 - 财政年份:2007
- 资助金额:
$ 3.97万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
- 批准号:
234753-2000 - 财政年份:2003
- 资助金额:
$ 3.97万 - 项目类别:
Collaborative Research and Development Grants